ChiCTR2000035108 版本V1.3 版本创建时间2020/07/31 23:49:55 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000035108 

最近更新日期:

Date of Last Refreshed on:

2020-07-31 23:46:33 

注册时间:

Date of Registration:

2020-07-31 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

喉镜下引起咽腔变化的口咽肌锻炼对OSAS患者的影响

Public title:

Effects of oropharyngeal exercises causing the pharynx cavity changes under the laryngoscope on patients with OSAS

注册题目简写:

English Acronym:

研究课题的正式科学名称:

喉镜下引起咽腔变化的口咽肌锻炼对OSAS患者的影响

Scientific title:

Effects of oropharyngeal exercises causing the pharynx cavity changes under the laryngoscope on patients with OSAS

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李丹阳 

研究负责人:

梁辉 

Applicant:

Danyang Li 

Study leader:

Hui Liang 

申请注册联系人电话:

Applicant telephone:

+86 17662395960

研究负责人电话:

Study leader's telephone:

+86 13791123898

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

15621579771@163.com

研究负责人电子邮件:

Study leader's E-mail:

onlinelh@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国山东省济南市历下区经十路16766号

研究负责人通讯地址:

中国山东省济南市历下区经十路16766号

Applicant address:

16766 Jingshi Road, Lixia District, Ji'nan, Shandong, China

Study leader's address:

16766 Jingshi Road, Lixia District, Ji'nan, Shandong, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

山东省千佛山医院

Applicant's institution:

Shandong Province Qianfoshan Hospital

研究负责人所在单位:

山东省千佛山医院

Affiliation of the Leader:

Shandong Province Qianfoshan Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

YXLL-KY-2020(027)

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

山东省千佛山医院医学伦理委员会

Name of the ethic committee:

Independent Ethics Committee of Shandong Province Qianfoshan Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2020-07-23 00:00:00

伦理委员会联系人:

张加胜

Contact Name of the ethic committee:

Jiasheng Zhang

伦理委员会联系地址:

中国山东省济南市历下区经十路16766号

Contact Address of the ethic committee:

16766 Jingshi Road, Lixia District, Ji'nan, Shandong, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

山东省千佛山医院

Primary sponsor:

Shandong Province Qianfoshan Hospital

研究实施负责(组长)单位地址:

中国山东省济南市历下区经十路16766号

Primary sponsor's address:

16766 Jingshi Road, Lixia District, Ji'nan, Shandong, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山东

市(区县):

济南

Country:

China

Province:

Shandong

City:

Ji'nan

单位(医院):

山东省千佛山医院

具体地址:

历下区经十路16766号

Institution
hospital:

Shandong Province Qianfoshan Hospital

Address:

16766 Jingshi Road, Lixia District

经费或物资来源:

自筹

Source(s) of funding:

self-funded

Target disease:

OSAS

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1、通过比较治疗前后结果,证实引起咽腔变化的口咽肌锻炼对OSAS患者更有效。 2、为口咽肌锻炼的简化及规范提供参考。  

Objectives of Study:

1. By comparing the results, oropharyngeal exercises causing changes in the pharynx cavity, will be proved more effective in patients with OSAS. 2. It provides reference for the simplification and standardization of oropharyngeal exercises.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1) 阻塞性睡眠呼吸暂停综合征患者;
2)年龄25-65岁;
3)体重指数(BMI) < 40kg/m2;

Inclusion criteria

1) Patients with OSAS;
2) Patients aged 25-65 years;
3) BMI < 40kg/m2;

排除标准:

1)既往其他睡眠障碍;
2)曾接受过阻塞性睡眠呼吸暂停(OSA)的治疗,如CPAP、口腔内器械或手术;
3)严重或失代偿的临床或精神疾病;
4)使用酒精、兴奋剂或镇静剂;
5)颅面或上呼吸道解剖改变;
6)正参加其它临床试验的患者;
7)研究人员认为其他原因不适合临床试验者;
8)不同意的个人和受教育程度较低的病人被排除在外,因为不具有知情同意的能力和理解问卷的能力。

Exclusion criteria:

1) Previous sleep disorders;
2) Patients who had been treated for OSA;
3) Neurological or mental illness;
4) Alcohol or drug abuse;
5) Craniofacial malformations or upper airway anatomic changes;
6) Patients participating in other clinical trials;
7) Other reasons that researchers think are inappropriate for clinical trials;
8) Patients who disagree/Less educatied patients.

研究实施时间:

Study execute time:

From 2020-08-01 00:00:00 To 2021-07-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-08-01 00:00:00 To 2021-01-31 00:00:00  

干预措施:

Interventions:

组别:

Group 1

样本量:

30

Group:

Group 1

Sample size:

干预措施:

喉镜下可见咽腔变化的口咽肌锻炼

干预措施代码:

Intervention:

oropharyngeal exercises causing the pharynx cavity changes under the laryngoscope

Intervention code:

组别:

Group 2

样本量:

30

Group:

Group 2

Sample size:

干预措施:

喉镜下无咽腔变化的口咽肌锻炼

干预措施代码:

Intervention:

oropharyngeal exercises causing no change in the pharynx cavity under the laryngoscope

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山东 

市(区县):

 

Country:

China 

Province:

Shandong 

City:

 

单位(医院):

山东省千佛山医院 

单位级别:

三级甲等 

Institution
hospital:

Shandong Province Qianfoshan Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

呼吸暂停低通气指数

指标类型:

主要指标

Outcome:

AHI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

最低血氧饱和度

指标类型:

主要指标

Outcome:

LspO2

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

嗜睡评分量表

指标类型:

次要指标

Outcome:

ESS

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

项目负责人使用电脑随机数字法

Randomization Procedure (please state who generates the random number sequence and by what method):

Computer-generated random number is used by PI.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

通过网络以发表文章的方式进行数据共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Share data by publishing articles on the Internet

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集及管理使用病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection and management using CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2020-07-31 23:36:32